Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HMOX1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HMOX1 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with Aging, Als, Atherosclerosis. Connected to 258 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | HMOX1 |
| Full Name | Heme Oxygenase 1 |
| Chromosome | 22q12 |
| Protein Type | Enzyme |
| Function | HMOX1 degrades heme to produce biliverdin (which is further converted to bilirubin), iron (which induces ferritin), and carbon monoxide (a signaling molecule). |
| Pathways | Autophagy, Chaperone, Immune Response, Mitophagy, Oxidative Stress |
| UniProt ID | P09601 |
| NCBI Gene ID | 3162 |
| Ensembl ID | ENSG00000101129 |
| OMIM | 141250 |
| GeneCards | HMOX1 |
| Human Protein Atlas | HMOX1 |
| Associated Diseases | Aging, Als, Alzheimer, Atherosclerosis, Diabetes |
| Known Drugs/Compounds | L. reuteri-CMVs, rapamycin |
| Interactions | ACHE, AKK, ALOX12, ALOX15, ALOX5, ALOXE3 |
| KG Connections | 501 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
NFE2L2["NFE2L2
(NRF2 gene)"] -->|"activates"| HMOX1["HMOX1
(Heme Oxygenase-1)"]
NRF2_protein["NRF2
(protein)"] -->|"regulates"| HMOX1
HIF1["HIF1
(pathway)"] -->|"activates"| HMOX1
L_reuteri["L. reuteri-CMVs
(therapeutic)"] -->|"activates"| HMOX1
HMOX1 -->|"inhibits"| ferroptosis["Ferroptosis
(cell death)"]
HMOX1 -->|"inhibits"| inflammation_pheno["Neuroinflammation
(process)"]
HMOX1 -->|"activates"| NFE2L2
HMOX1 -->|"activates"| ALOX15["ALOX15
(lipoxygenase)"]
HMOX1 -->|"activates"| ALOX12["ALOX12
(lipoxygenase)"]
HMOX1 -->|"therapeutic_target"| MS["Multiple Sclerosis
(MS)"]
HMOX1 -->|"therapeutic_target"| Stroke["Stroke
(cerebrovascular)"]
HMOX1 -->|"therapeutic_target"| Ischemia["Brain Ischemia
(hypoxia)"]
HMOX1 -->|"associated_with"| ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
HMOX1 -->|"regulates"| Aging["Neuronal Aging
(senescence)"]
ferroptosis --> neurodegeneration["Neurodegeneration
(outcome)"]
inflammation_pheno --> neurodegeneration
MS --> neurodegeneration
ALS --> neurodegeneration
style HMOX1 fill:#006494
style ferroptosis fill:#ef5350
style inflammation_pheno fill:#ef5350
style neurodegeneration fill:#5d4400
style NFE2L2 fill:#4a1a6b
style NRF2_protein fill:#4a1a6b
style L_reuteri fill:#1b5e20
style MS fill:#ef5350
style ALS fill:#ef5350
style Stroke fill:#ef5350
style Ischemia fill:#ef5350
style Aging fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | inhibits | process | 0.85 |
| Ferroptosis | associated_with | process | 0.85 |
| ferroptosis | promotes | process | 0.82 |
| FERROPTOSIS | activates | gene | 0.80 |
| Ferroptosis | activates | pathway | 0.80 |
| Aging | regulates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Oxidative Stress | protects_against | process | 0.75 |
| Inflammation | activates | disease | 0.75 |
| INFLAMMATION | activates | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| neuroprotection | protective_against | phenotype | 0.70 |
| MAPK signaling | participates_in | pathway | 0.70 |
| Neuroprotection | protective_against | phenotype | 0.70 |
| FERROPTOSIS | associated_with | gene | 0.70 |
| GENES | biomarker_for | gene | 0.70 |
| Parkinson's disease | protective_against | disease | 0.70 |
| GENES | activates | gene | 0.70 |
| Oxidative Stress | associated_with | pathway | 0.70 |
| Nafld | activates | disease | 0.65 |
| Cardiac | regulates | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Hepatocellular Carcinoma | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ischemia | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Metabolic Syndrome | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Liver Cancer | activates | disease | 0.65 |
| Cardiac | activates | disease | 0.65 |
| Fatty Liver | activates | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Heart Failure | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IPA | upregulates | compound | 0.95 |
| NFE2L2 | upregulates | gene | 0.90 |
| NFE2L2 | regulates | gene | 0.90 |
| NRF2 | regulates | protein | 0.87 |
| SBFI26 | upregulates | drug | 0.85 |
| L. reuteri-CMVs | activates | drug | 0.80 |
| NFE2L2 | activates | gene | 0.72 |
| GPX4 | activates | gene | 0.70 |
| KEAP1 | activates | gene | 0.70 |
| HIF1 | activates | pathway | 0.64 |
| TRPA1 | regulates | gene | 0.60 |
| CXCL2 | regulates | gene | 0.60 |
| SNAP25 | regulates | gene | 0.60 |
| P2RX7 | regulates | gene | 0.60 |
| SYT2 | regulates | gene | 0.60 |
| TNF | regulates | gene | 0.60 |
| SOD2 | regulates | gene | 0.60 |
| NOS2 | regulates | gene | 0.60 |
| P2RX3 | regulates | gene | 0.60 |
| RELA | regulates | gene | 0.60 |
| SYP | regulates | gene | 0.60 |
| CHRNA7 | regulates | gene | 0.60 |
| SYT1 | regulates | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| ALOX12 | activates | gene | 0.60 |
| ALOX15 | activates | gene | 0.60 |
| FER | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| GPX4 | associated_with | gene | 0.60 |
| NQO2 | associated_with | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| NOS2 | therapeutic_target | gene | 0.60 |
| AKT1 | therapeutic_target | gene | 0.60 |
| IL1B | therapeutic_target | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| CASP1 | associated_with | gene | 0.60 |
| NAMPT | associated_with | gene | 0.60 |
| BAX | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| HMGB1 | expressed_in | gene | 0.60 |
| HMGB1 | implicated_in | gene | 0.60 |
| CAT | activates | gene | 0.60 |
| ADRB2 | targets | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| SOCS3 | regulates | gene | 0.60 |
| CASP3 | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| SAT1 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.661
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586
neurodegeneration | 2026-04-01 | 5 hypotheses Top: 0.720
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.82 · 2026-04-22
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-15
Hypotheses and analyses mentioning HMOX1 in their description or question text
No additional research found